Trademark: 88602178
Word
CUREVAC
Status
Registered
Status Code
700
Status Date
Tuesday, April 13, 2021
Serial Number
88602178
Registration Number
6318156
Registration Date
Tuesday, April 13, 2021
Mark Type
3000
Filing Date
Tuesday, September 3, 2019
Published for Opposition
Tuesday, January 26, 2021

Trademark Owner History
CUREVAC SE -
CureVac AG - Original Registrant

Classifications
5 Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Peptide carrier molecules for association with a biological macromolecule, for medical use, namely, for use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier molecule, sold in combination with a biological macromolecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
1 Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
44 Medical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
42 Scientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules
The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.
In the statement, line 2, "Paul-Ehrlich-Str. 15" should be deleted, and "Friedrich-Miescher-Str. 15" should be inserted.
CURE VAC
The color(s) orange and blue is/are claimed as a feature of the mark.

Trademark Events
Mar 8, 2023
Automatic Update Of Assignment Of Ownership
Sep 30, 2021
Correction Under Section 7 ¿ Processed
Sep 30, 2021
Case Assigned To Post Registration Paralegal
Apr 30, 2021
Teas Section 7 Request Received
Apr 13, 2021
Registered-Principal Register
Jan 26, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 26, 2021
Published For Opposition
Jan 6, 2021
Notification Of Notice Of Publication E-Mailed
Dec 17, 2020
Approved For Pub - Principal Register
Dec 17, 2020
Examiner's Amendment Entered
Dec 17, 2020
Notification Of Examiners Amendment E-Mailed
Dec 17, 2020
Examiners Amendment E-Mailed
Dec 17, 2020
Examiners Amendment -Written
Dec 16, 2020
Teas/Email Correspondence Entered
Dec 16, 2020
Correspondence Received In Law Office
Dec 15, 2020
Teas Response To Office Action Received
Jun 30, 2020
Notification Of Non-Final Action E-Mailed
Jun 30, 2020
Non-Final Action E-Mailed
Jun 30, 2020
Non-Final Action Written
Jun 16, 2020
Teas/Email Correspondence Entered
Jun 16, 2020
Correspondence Received In Law Office
Jun 15, 2020
Assigned To Lie
Jun 4, 2020
Teas Response To Office Action Received
Dec 9, 2019
Notification Of Non-Final Action E-Mailed
Dec 9, 2019
Non-Final Action E-Mailed
Dec 9, 2019
Non-Final Action Written
Dec 5, 2019
Assigned To Examiner
Sep 14, 2019
Notice Of Design Search Code E-Mailed
Sep 13, 2019
New Application Office Supplied Data Entered
Sep 6, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24